Novel coronavirus variation analysis method
Through nucleic acid extraction, whole genome sequencing and mutation site analysis, combined with Nextclade and VarEPS systems, the mutation risk of the novel coronavirus mutant strain was evaluated, solving the problem of the mutant strain breaking through the immune barrier, and achieving a comprehensive analysis and prediction of the mutation pattern.
Patent Information
- Application Number
- CN202411109550.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-13
- Publication Date
- 2024-11-15
AI Technical Summary
The mutant strain of the novel coronavirus breaks through the immune barriers conferred by previous infections and vaccines, resulting in increased difficulty in assessing mutation risk. The existing technology mainly focuses on the mutation trend of the spike S protein region, but it is difficult to comprehensively analyze the mutation pattern and its impact on virus transmission. .
The effects of S protein region mutations on virus transmission and adaptability were evaluated using nucleic acid extraction, whole genome-targeted amplification, sequencing, genotyping, sequence quality evaluation and mutation site analysis.
Analyzing the strain mutation rules from the genetic and protein molecular level, providing rapid mutation risk assessment, and improving the predictive ability and analysis efficiency of novel coronavirus mutations.
Smart Images

Figure CN118957151A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of virus detection and analysis, and specifically to a method for analyzing the mutation of a novel coronavirus. Background Art
[0002] As we all know, the rapid spread of the new coronavirus (Severe acute respiratory syndrome coronavirus2, SARS-CoV-2) has triggered a global public health event. It is an RNA virus that is prone to mutation during its widespread spread. Among them, some variants of the new coronavirus have broken through the immune barriers conferred by previous infections and vaccines and quickly become the main epidemic strains in the world, especially the Omicron variant and its branches, such as the JN.1 series of variants. In order to analyze the mutated new coronavirus, current research mainly focuses on the mutation trends of key sites in the spike S protein region that mediate viral invasion, including the receptor binding domain RBD, receptor binding motif RBM, N-terminal domain NTD, Furin cleavage site, fusion peptide FP, etc. Therefore, it is very important to assess the mutation risk of the new coronavirus. Summary of the invention
[0003] To this end, the present invention provides a method for analyzing the mutation of the new coronavirus to solve the above-mentioned problems in the prior art.
[0004] In order to achieve the above object, the present invention provides the following technical solutions:
[0005] According to the first aspect of the present invention, a method for analyzing a variation of a novel coronavirus mainly comprises the following steps:
[0006] S1. Extraction and testing of nucleic acid of the new coronavirus;
[0007] S2. Perform targeted amplification of the whole genome of the novel coronavirus;
[0008] S3. Conduct whole genome sequencing of the novel coronavirus;
[0009] S4. Genotyping of the novel coronavirus;
[0010] S5. Evaluate the sequence quality of the obtained fasta files and screen the sequences that meet the inclusion criteria;
[0011] S6. Analyze the nucleotide and amino acid mutation sites of the screened high-quality sequences.
[0012] Furthermore: The specific method of step S2 is: using an ultra-sensitive new coronavirus whole genome capture kit and a PCR instrument to complete nucleic acid reverse transcription and targeted amplification of the new coronavirus whole genome, and the targeted amplification is completed using a 1200bp primer system divided into two primer pools.
[0013] Further: the PCR amplification reaction conditions of the PCR instrument are: 98°C for 30s; 98°C for 15s, 63°C for 5min, 5 cycles; 98°C for 15s, 65°C for 4min, 25 cycles; 72°C for 2min, 1 cycle.
[0014] Furthermore: The specific method of step S3 is: using a nanopore sequencing platform to complete the whole genome sequence determination of the new coronavirus, and using a rapid barcode sequencing kit to complete library construction, including DNA fragmentation and labeling, merging barcoded samples, connecting sequencing adapters, chip pretreatment and loading.
[0015] Further: The specific steps of constructing the library are:
[0016] (1) The initial DNA input amount is 400 ng;
[0017] (2) Purify the library during library construction;
[0018] (3) Quantify the library using a high-sensitivity quantitative kit and a fluorometer;
[0019] (4) Use sequencing chips and sequencers to complete sequence determination;
[0020] (5) MinKNOW software was used to set the sequencing parameters, the base recognition mode was set to ultra-precision mode, and the minimum quality value was set to 10.
[0021] Further: The specific method of step S4 is: use the new crown analysis module of the Baiyi analysis software to complete the sequencing data quality assessment and the assembly of the new coronavirus genome, and then perform genotyping on the obtained fasta file through the Pangolin online analysis tool.
[0022] Furthermore: the thresholds of the Pangolin online analysis tool are set as Scorpio support>0.9 and Scorpio conflict<0.05.
[0023] Furthermore: the specific method of step S6 is to upload the screened sequence to the Nextclade online analysis tool for nucleotide and amino acid mutation site analysis; perform data collation and statistical analysis on the mutation sites; for high-frequency mutation sites or mutation sites with a clear upward trend in the S protein region, use the VarEPS system to evaluate the effects of mutations on the affinity of the S protein and neutralizing antibodies, and on the binding stability of the S protein to the ACE2 receptor, calculate the mutation accumulation rate, predict the effects of amino acid mutations on the biological functions of the protein, and then complete the assessment of mutation risk.
[0024] The present invention has the following advantages: it analyzes the variation rules of virus strains from the gene and protein molecule levels and can predict the impact of key variation on virus transmission and adaptability based on the variation rules; the tools used in the variation method of the present invention are all existing tools, which can greatly improve the effectiveness and provide rapid preliminary variation analysis. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 This is a flow chart of a method for analyzing a variation of a novel coronavirus according to the present invention. DETAILED DESCRIPTION
[0026] The following is an explanation of the implementation of the present invention by specific specific examples. People familiar with this technology can easily understand other advantages and effects of the present invention from the contents disclosed in this specification. Obviously, the described embodiments are part of the embodiments of the present invention, not all of them. It should be understood that these embodiments are only to further illustrate the present invention and cannot be understood as limiting the scope of protection of the present invention. Technical engineers in this field can make some non-essential improvements and adjustments to the present invention based on the contents of the above invention; based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0027] like Figure 1 As shown, a method for analyzing the mutation of a novel coronavirus specifically comprises the following steps:
[0028] S1. Extract and test the nucleic acid of the new coronavirus. Use a virus extraction kit and an automatic nucleic acid extractor to extract the nucleic acid of the new coronavirus, and store the extracted virus product at a low temperature of -20°C for use. Use the new coronavirus nucleic acid detection fluorescent PCR kit and a fluorescent quantitative PCR instrument to test and test the collected samples. Randomly select specimens that meet the sequencing requirements, that is, specimens with a Ct value of <32, and complete the sequence determination within 72 hours.
[0029] S2. Perform targeted amplification of the whole genome of the new coronavirus using an ultra-sensitive new coronavirus whole genome capture kit and a PCR instrument to complete nucleic acid reverse transcription and targeted amplification of the whole genome of the new coronavirus. The targeted amplification is completed using a 1200bp primer system divided into two primer pools.
[0030] The PCR amplification reaction conditions were as follows: 98°C for 30 s; 98°C for 15 s, 63°C for 5 min, 5 cycles; 98°C for 15 s, 65°C for 4 min, 25 cycles; 72°C for 2 min, 1 cycle.
[0031] S3. Perform whole genome sequencing of the novel coronavirus. Use nanopore sequencing platform to complete the whole genome sequence determination of the novel coronavirus. Use rapid barcode sequencing kit to complete library construction, which mainly includes DNA fragmentation and labeling, merging barcoded samples, connecting sequencing adapters, chip pretreatment and loading, etc.
[0032] The specific steps for constructing the above library are as follows: (1) the initial DNA input amount is 400 ng; (2) the library is purified during the library construction process, specifically using AMPure XP magnetic beads for purification; (3) the library is quantified using a high-sensitivity quantitative kit and a fluorescence instrument; (4) sequencing is completed using a sequencing chip and a sequencer. In this embodiment, a MinION sequencing chip and a GridION X5 sequencer are used; (5) sequencing parameters are set using MinKNOW software, wherein the base recognition mode is set to the ultra-precision mode and the minimum quality value is set to 10.
[0033] S4. Genotyping of the novel coronavirus was performed using the COVID-19 analysis module of the Baiyi analysis software to complete sequencing data quality assessment and assembly of the novel coronavirus genome. The obtained fasta file was then used for genotyping using the Pangolin online analysis tool. During this online analysis, the Pangolin thresholds were set to Scorpio support > 0.9 and Scorpio conflict < 0.05.
[0034] S5. Perform sequence quality assessment on the obtained FASTA files and screen the sequences that meet the inclusion criteria to facilitate subsequent analysis of the screened high-quality sequences.
[0035] S6. Analyze the nucleotide and amino acid mutation sites of the screened high-quality sequences; upload the screened sequences to the Nextclade online analysis tool for nucleotide and amino acid mutation site analysis; organize data and perform statistical analysis on the mutation sites; for high-frequency mutation sites or mutation sites with a clear upward trend in the S protein region, use the VarEPS system to evaluate the effects of mutations on the affinity of the S protein and neutralizing antibodies, and on the binding stability of the S protein with the ACE2 receptor, calculate the mutation accumulation rate, and predict the effects of amino acid mutations on the biological functions of the protein, thereby completing the assessment of mutation risk.
[0036] The amino acid mutation sites located in the key domains of the S protein were selected, and a cluster heat map was drawn according to the detection frequency of each mutation site in different time periods to assist in analyzing the changing trend of the site mutation frequency. During the analysis, based on previous research experience, special attention was paid to some amino acid sites G446V to G446S, T478K to T478R / N, F486I / V to F486S / P in the receptor binding motif RBM region, sites W152R, F157L, I210V in the N-terminal domain NTD region, and other high-frequency sites G798D, N1125S, I1216T, I1221T, P812L, L822F1, H1058Y, G1099D, T1116A, Q1142R, and D1259Y in the above high-frequency mutation sites.
[0037] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for analyzing the mutation of a novel coronavirus, characterized in that: The specific steps include: S1. Extraction and testing of nucleic acid of novel coronavirus; S2. Perform targeted amplification of the whole genome of the novel coronavirus; S3. Conduct whole genome sequencing of the novel coronavirus; S4. Genotyping of the novel coronavirus; S5. Evaluate the sequence quality of the obtained fasta files and screen the sequences that meet the inclusion criteria; S6. Analyze the nucleotide and amino acid mutation sites of the screened high-quality sequences.
2. The method for analyzing the variation of a novel coronavirus according to claim 1, characterized in that: The specific method of step S2 is: using an ultra-sensitive new coronavirus whole genome capture kit and a PCR instrument to complete nucleic acid reverse transcription and targeted amplification of the new coronavirus whole genome, and the targeted amplification is completed using a 1200bp primer system divided into two primer pools.
3. The method for analyzing the variation of a novel coronavirus according to claim 2, characterized in that: The PCR amplification reaction conditions of the PCR instrument are: 98°C for 30s; 98°C for 15s, 63°C for 5min, 5 cycles; 98°C for 15s, 65°C for 4min, 25 cycles; 72°C for 2min, 1 cycle.
4. The method for analyzing the variation of a novel coronavirus according to claim 1, characterized in that: The specific method of step S3 is: using a nanopore sequencing platform to complete the whole genome sequence determination of the new coronavirus, and using a rapid barcode sequencing kit to complete library construction, including DNA fragmentation and labeling, merging barcoded samples, connecting sequencing adapters, chip pretreatment and loading.
5. The method for analyzing the variation of a novel coronavirus according to claim 4, characterized in that: The specific steps of constructing the library are: (1) The initial DNA input amount is 400 ng; (2) Purify the library during library construction; (3) Quantify the library using a high-sensitivity quantitative kit and a fluorometer; (4) Use sequencing chips and sequencers to complete sequence determination; (5) MinKNOW software was used to set the sequencing parameters, the base recognition mode was set to the ultra-precision mode, and the minimum quality value was set to 10.
6. The method for analyzing a variation of a novel coronavirus according to claim 1, characterized in that: The specific method of step S4 is: use the new crown analysis module of the Baiyi analysis software to complete the sequencing data quality assessment and the assembly of the new coronavirus genome, and then perform genotyping on the obtained fasta file through the Pangolin online analysis tool.
7. The method for analyzing the variation of a novel coronavirus according to claim 6, characterized in that: The thresholds of the Pangolin online analysis tool were set as Scorpio support>0.9 and Scorpio conflict<0.
05.
8. The method for analyzing the variation of a novel coronavirus according to claim 1, characterized in that: The specific method of step S6 is to upload the screened sequence to the Nextclade online analysis tool for nucleotide and amino acid mutation site analysis; perform data collation and statistical analysis on the mutation sites; for high-frequency mutation sites or mutation sites with a clear upward trend in the S protein region, use the VarEPS system to evaluate the effects of mutations on the affinity of the S protein and neutralizing antibodies, and on the binding stability of the S protein to the ACE2 receptor, calculate the mutation accumulation rate, predict the effects of amino acid mutations on the biological functions of the protein, and then complete the assessment of mutation risk.
Citation Information
Cited By
Deep learning-based early warning method for new variants of respiratory viruses
CN120544672A
A deep learning-based early warning method for respiratory virus new variants
CN120544672B
